DK173375B1 - LHRH-Antagonister, deres fremstilling og lægemidler der indeholder dem - Google Patents

LHRH-Antagonister, deres fremstilling og lægemidler der indeholder dem Download PDF

Info

Publication number
DK173375B1
DK173375B1 DK198803956A DK395688A DK173375B1 DK 173375 B1 DK173375 B1 DK 173375B1 DK 198803956 A DK198803956 A DK 198803956A DK 395688 A DK395688 A DK 395688A DK 173375 B1 DK173375 B1 DK 173375B1
Authority
DK
Denmark
Prior art keywords
phe
peptide
nal
pro
group
Prior art date
Application number
DK198803956A
Other languages
Danish (da)
English (en)
Other versions
DK395688A (da
DK395688D0 (da
Inventor
Andrew V Schally
Sandor Bajusz
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of DK395688D0 publication Critical patent/DK395688D0/da
Publication of DK395688A publication Critical patent/DK395688A/da
Application granted granted Critical
Publication of DK173375B1 publication Critical patent/DK173375B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK198803956A 1987-07-17 1988-07-15 LHRH-Antagonister, deres fremstilling og lægemidler der indeholder dem DK173375B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7412687 1987-07-17
US07/074,126 US4800191A (en) 1987-07-17 1987-07-17 LHRH antagonists

Publications (3)

Publication Number Publication Date
DK395688D0 DK395688D0 (da) 1988-07-15
DK395688A DK395688A (da) 1989-01-18
DK173375B1 true DK173375B1 (da) 2000-09-11

Family

ID=22117877

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803956A DK173375B1 (da) 1987-07-17 1988-07-15 LHRH-Antagonister, deres fremstilling og lægemidler der indeholder dem

Country Status (18)

Country Link
US (2) US4800191A (pt)
EP (1) EP0299402B1 (pt)
JP (1) JP2944669B2 (pt)
AT (1) ATE90362T1 (pt)
BR (1) BR1100478A (pt)
CA (1) CA1339623C (pt)
DE (3) DE3881592D1 (pt)
DK (1) DK173375B1 (pt)
ES (1) ES2054741T3 (pt)
FI (1) FI91075C (pt)
HK (1) HK21194A (pt)
HU (1) HU206376B (pt)
IE (1) IE62744B1 (pt)
LU (1) LU90425I2 (pt)
LV (1) LV5795B4 (pt)
NL (1) NL990029I2 (pt)
PT (1) PT87998B (pt)
ZA (1) ZA885147B (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists
US5171835A (en) * 1988-10-21 1992-12-15 The Administrators Of The Tulane Educational Fund LHRH antagonists
US5169932A (en) * 1989-10-30 1992-12-08 The Salk Institute For Biological Studies Gnrh analogs
US5064939A (en) * 1990-02-06 1991-11-12 The Salk Institute For Biological Studies Cyclic gnrh antagonists
HU208158B (en) * 1990-02-20 1993-08-30 Syntex Inc Process for the synthesis of 1h-rh analogs by temporary protection
US5516887A (en) * 1991-04-25 1996-05-14 Romano Deghenghi Luteinizing hormone releasing hormone antagonist peptides
DE4117507A1 (de) * 1991-05-24 1992-11-26 Schering Ag Verfahren zur herstellung von n(pfeil hoch)6(pfeil hoch)-substituierten lysin-derivaten
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
WO1993003752A1 (en) * 1991-08-19 1993-03-04 The Arizona Board Of Regents On Behalf Of The University Of Arizona Decapeptide having dopamine stimulating activity
US6468959B1 (en) * 1991-12-05 2002-10-22 Alfatec-Pharm Gmbh Peroral dosage form for peptide containing medicaments, in particular insulin
BE1005720A3 (fr) * 1992-03-20 1993-12-28 Solvay Procede de synthese peptidique et nouveaux intermediaires de synthese.
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
BE1007183A3 (fr) * 1993-06-18 1995-04-18 Solvay Ureines derivees d'alpha, omega-diaminoacides et procede pour leur preparation.
DE4320201A1 (de) * 1993-06-18 1995-01-12 Asta Medica Ag Verwendung von Cetrorelix und weiteren Nona- und Dekapeptiden zur Herstellung eines Arzneimittels zur Bekämpfung von Aids und zur Wachstumsstimulation
US5413990A (en) * 1993-08-06 1995-05-09 Tap Pharmaceuticals Inc. N-terminus modified analogs of LHRH
WO1995004541A1 (en) * 1993-08-06 1995-02-16 Abbott Laboratories N-terminus modified analogs of lhrh
US5502035A (en) * 1993-08-06 1996-03-26 Tap Holdings Inc. N-terminus modified analogs of LHRH
US6913767B1 (en) 1993-10-25 2005-07-05 Genentech, Inc. Compositions for microencapsulation of antigens for use as vaccines
US5643605A (en) * 1993-10-25 1997-07-01 Genentech, Inc. Methods and compositions for microencapsulation of adjuvants
US6080429A (en) * 1993-10-25 2000-06-27 Genentech, Inc. Method for drying microspheres
CA2178592C (en) * 1993-12-09 2009-07-28 Jurgen Engel Long-acting injection suspensions and a process for their preparation
DE4342091A1 (de) * 1993-12-09 1995-06-14 Asta Medica Ag Erzeugnisse zur Anwendung von initial hohen Dosen von Cetrorelix und Herstellung einer Kombinationspackung zur Verwendung bei Therapie von Krankheiten
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5916582A (en) * 1996-07-03 1999-06-29 Alza Corporation Aqueous formulations of peptides
US5932547A (en) * 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
US5981489A (en) * 1996-07-18 1999-11-09 Alza Corporation Non-aqueous protic peptide formulations
DE19644994A1 (de) * 1996-10-30 1998-05-07 Asta Medica Ag Diagnostisches Mittel
US5925730A (en) 1997-04-11 1999-07-20 Ferring Bv GnRH antagonists
US5821230A (en) * 1997-04-11 1998-10-13 Ferring Bv GnRH antagonist decapeptides
US6407205B1 (en) * 1997-06-04 2002-06-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College FSH-releasing peptides
DE19728737C1 (de) * 1997-07-04 1999-02-11 Johannes Christian Groeninghen Verfahren zur Erkennung und Bestimmung von GnRH-Rezeptoren und die Verwendung von GnRH-Agonisten und GnRH-Antagonisten zur Behandlung eines Tumors ausgehend vom Hirn und/oder Nervensystem und/oder den Hirnhäuten
US5941844A (en) * 1997-11-17 1999-08-24 Alza Corporation Method and device for controlling mammalian reproductive cycle
US6191115B1 (en) * 1998-08-12 2001-02-20 Abbott Laboratories C-terminus modified heptapeptide LHRH analogs
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
DE19911771B4 (de) * 1999-03-17 2006-03-30 Zentaris Gmbh LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
DE10040700A1 (de) * 2000-08-17 2002-02-28 Asta Medica Ag Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
WO2002047489A1 (en) 2000-12-15 2002-06-20 Wm. Wrigley Jr. Company Encapsulated acid mixtures and products including same
DE10157628A1 (de) * 2001-11-26 2003-06-12 Zentaris Ag Injektionslösung eines LHRH-Antagonisten
US7214662B2 (en) 2001-11-27 2007-05-08 Zentaris Gmbh Injectable solution of an LHRH antagonist
CN101647772A (zh) * 2008-08-12 2010-02-17 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂类物质的注射用缓释制剂及其制备
EP2379099A1 (en) 2009-01-22 2011-10-26 Maatschap Interne Geneeskunde Rijnstate Method for the prophylaxis or treatment of flushing
CN101863960B (zh) * 2009-04-15 2013-03-06 无锡市凯利药业有限公司 西曲瑞克的制备方法
EP2266567A1 (en) 2009-05-26 2010-12-29 Æterna Zentaris GmbH Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
JP2014502282A (ja) 2010-12-06 2014-01-30 アストロン リサーチ リミテッド 安定な使用準備済みセトロレリックス注射液
US20220233631A1 (en) 2019-06-17 2022-07-28 Intas Pharmaceuticals Ltd. Stable formulation of cetrorelix
CN111875673B (zh) * 2020-07-31 2022-03-11 江苏莱森生物科技研究院有限公司 一种具有抗肿瘤活性的多肽及其用途
CN112175043A (zh) * 2020-10-12 2021-01-05 湖南津安生物科技有限公司 一种改进的鲑鱼促性腺激素释放激素的固相合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3250759A (en) * 1961-08-18 1966-05-10 Olin Mathieson Citrulline containing peptides
AU9102582A (en) * 1981-12-10 1983-06-16 David Howard Coy Lh-rh antagonists
FI832053L (fi) * 1982-06-10 1983-12-11 Syntex Inc Nonapeptid- och dekapeptidanaloger av lhrh anvaendbara som lhrh-antagonister samt deras framstaellningsfoerfarande
EP0145032B1 (en) * 1983-08-16 1987-11-04 Akzo N.V. Lh- rh antagonists
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US4690916A (en) * 1984-11-13 1987-09-01 Syntex (U.S.A.) Inc. Nona and decapeptide analogs of LHRH useful as LHRH antagonists
US4677193A (en) * 1985-02-22 1987-06-30 The Salk Institute For Biological Studies Peptides containing an aliphatic-aromatic ketone side chain
EP0199302A2 (en) * 1985-04-19 1986-10-29 Syntex (U.S.A.) Inc. Contraception in dogs with luteinizing hormone releasing hormone antagonists
US4800191A (en) * 1987-07-17 1989-01-24 Schally Andrew Victor LHRH antagonists

Also Published As

Publication number Publication date
US5198533A (en) 1993-03-30
BR1100478A (pt) 2000-03-14
FI883388A (fi) 1989-01-18
IE882185L (en) 1989-01-17
HUT47311A (en) 1989-02-28
US4800191A (en) 1989-01-24
LV5795A4 (lv) 1997-02-20
JPS6434997A (en) 1989-02-06
DK395688A (da) 1989-01-18
FI91075C (fi) 1994-05-10
DE19975052I2 (de) 2009-01-02
HK21194A (en) 1994-03-18
JP2944669B2 (ja) 1999-09-06
DE3881592D1 (de) 1993-07-15
LV5795B4 (lv) 1997-08-20
HU206376B (en) 1992-10-28
EP0299402B1 (de) 1993-06-09
EP0299402A2 (de) 1989-01-18
ZA885147B (en) 1989-04-26
PT87998A (pt) 1989-06-30
DK395688D0 (da) 1988-07-15
NL990029I2 (nl) 2000-03-01
DE3823590A1 (de) 1989-01-26
NL990029I1 (nl) 1999-12-01
CA1339623C (en) 1998-01-06
ES2054741T3 (es) 1994-08-16
FI91075B (fi) 1994-01-31
LU90425I2 (fr) 1999-10-04
PT87998B (pt) 1995-03-01
FI883388A0 (fi) 1988-07-15
ATE90362T1 (de) 1993-06-15
EP0299402A3 (en) 1990-06-06
IE62744B1 (en) 1995-02-22

Similar Documents

Publication Publication Date Title
DK173375B1 (da) LHRH-Antagonister, deres fremstilling og lægemidler der indeholder dem
US5470947A (en) CHRH antagonists with low histamine release
DK173544B1 (da) Nona- og decapeptider med LHRH antagonist aktivitet, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeh
AU675274B2 (en) Reduced size LHRH analogs
EP0500695B1 (en) GnRH ANALOGS
US5171835A (en) LHRH antagonists
NO324991B1 (no) GnRH antagonistpeptid samt farmasoytisk preparat inneholdende det samme.
US5244883A (en) Nonapeptide bombesin antagonists
DK167361B1 (da) Grf-analoge peptider, farmaceutisk acceptable salte heraf og fremgangsmaader til fremstilling af disse
NZ209357A (en) Polypeptides,(44 amino acid residue) having growth hormone releasing properties; growth promoting compositions
US5258492A (en) LHRH analogues with cytotoxic moieties at the sixth position
FI81589B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara grf-peptidanaloger.
US4721775A (en) Effective peptides related to the luteinizing hormone releasing hormone from L-amino acids
EP0125290B1 (en) Peptides affecting gonadal function
FI79716B (fi) Daeggdjur-pgrf.
Fisher et al. Hypothalamic hormones. 71. Synthesis and some biological activities of the tyrosine-8 analog of substance P
JPH01199997A (ja) 哺乳動物の脳下垂体に作用するペプチド
US4643989A (en) Inhibition of aldosterone secretion
FI101884B (fi) Luteinisoivaa hormonia vapauttavan hormonin (LHRH) antagonistipeptidej ä
WO1992002237A1 (en) Analogs of endothelin
EP0364819A2 (en) LHRH analogs
IE892496A1 (en) Ghrh analogs

Legal Events

Date Code Title Description
CTFG Supplementary protection certificate (spc) issued

Free format text: PRODUCT NAME: CETRORELIX ACETAT

Spc suppl protection certif: CA 2000 00017

Filing date: 20000926

PUP Patent expired